You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

What is meningococcal meningitis?

Meningococcal meningitis is a bacterial infection caused by the bacterium Neisseria meningitides. It affects the covering of the brain and the spinal cord.

It can present as meningitis and or septicaemia (blood poisoning). Symptoms include fever, headache and neck stiffness, and these are sometimes accompanied by a rash. Meningococcal meningitis can be fatal, and for some survivors there are long-term complications.

There are different types of meningococcal meningitis. Five types cause most of the disease in humans: A, B, C, W and Y.

What is Menveo and what is it used for?

Menveo is a vaccine which helps prevent meningococcal meningitis types A, C, W and Y, known as a Meningitis ACWY vaccine. When you are given the vaccine your body will make antibodies (your body’s natural defence system) against the Neisseria meningitides bacterium. This will help protect you against meningococcal meningitis types A, C, W and Y.

Who may be recommended to receive a Meningitits ACWY vaccine?

There is a national immunisation programme that protects teenagers and ‘fresher’ students up to the age of 25. For more information, visit NHS Choices, Immunisation Scotland or NI Direct.

Travellers who may require a Meningitis ACWY vaccine include  those travelling to parts of Africa, and those travelling to Mecca in Saudi Arabia for the Hajj or Umrah pilgrimage. It is a visa requirement for pilgrims and seasonal workers travelling to Saudi Arabia to have proof of having received a Meningitis ACWY vaccine.

Your doctor can advise you on whether you are recommended to receive the Menveo vaccine.

How is Menveo given?

Menveo is injected into the muscle in your upper arm. The vaccine is suitable for those aged two years and older.

For further information on Menveo please see :

Menveo patient information leaflet (PIL)
Menveo summary of product characteristics (SPC)

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.

Menveo is a registered trademark of the GlaxoSmithKline group of companies.